UnissResearch

Logo Universitàegli studi di Sassari
titoli, abstracts, parole chiave >>>
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC

Calvisi, Diego Francesco and Ladu, Sara and Gorden, Alexis and Conner, Elizabeth A. and Lee, Ju-Seog and Factor, Valentina M. and Thorgeirsson, Snorri S. (2006) Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology, Vol. 130 (4), p. 1117-1128. ISSN 0016-5085. Article.

Full text not available from this repository.

DOI: 10.1053/j.gastro.2006.01.006

Abstract

Background & Aims: Although the natural history and pathologic characteristics of human hepatocellular carcinoma (HCC) are well documented, the molecular pathogenesis of HCC remains poorly understood. Here, we define the role for Ras and Janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathways in human HCC. Methods: Promoter and genomic status of Ras and Jak/Stat inhibitors were assessed in 80 HCCs by methylation-specific polymerase chain reaction and microsatellite analysis. Activation of Ras and Jak/Stat signaling pathways was determined by DNA sequencing, Western blot, and immunoprecipitation analysis. Suppression of Ras and Jak/Stat pathways in HCC cell lines was evaluated by viability and apoptosis assays. Results: Activation of Ras and Jak/Stat pathways was enhanced in all HCCs when compared with nonneoplastic surrounding and normal livers coincidently with the suppression of at least 1 Ras (RASSF1A and/or NORE1A) and 2 Jak/Stat inhibitors (cytokine-inducible SH2-protein [CIS]; suppressor of cytokine signaling [SOCS]1, 2, 3; and SH2-containing phosphatases [SHP1]). HCC associated with cirrhosis showed significantly higher frequency of RASSF1A, CIS, and SOCS1 promoter methylation than HCC without cirrhosis (P < .002, P < .02, and P < .02, respectively). Furthermore, aberrant methylation of NORE1A and SOCS3 promoters was observed only in a subclass of HCC with poor survival, suggesting that inactivation of these 2 genes might be involved in HCC progression. Combined treatment of HCC cell lines with Ras and Jak/Stat inhibitors as well as with the demethylating agent zebularine induced a strong apoptotic response. Conclusions: These data demonstrate the ubiquitous activation of Ras and Jak/Stat pathways in HCC and suggest the potential use of Ras and Jak/Stat inhibitors and demethylating agents as therapeutic modality for human liver cancer.

Item Type:Article
ID Code:1309
Status:Published
Refereed:Yes
Uncontrolled Keywords:Human hepatocellular cercinoma (HCC), Ras, JAK/STAT pathway, pathogenesis, tumor
Subjects:Area 06 - Scienze mediche > MED/04 Patologia generale
Divisions:001 Università di Sassari > 01 Dipartimenti > Scienze biomediche
Publisher:Elsevier
ISSN:0016-5085
Copyright Holders:© 2006 American Gastroenterological Association Institute
Deposited On:18 Aug 2009 10:04

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page